Thrombin-receptor antagonist vorapaxar in acute coronary syndromes

: Tricoci P, Huang Z, Held C, Moliterno DJ, Armstrong PW, Van de Werf F, White HD, Aylward PE, Wallentin L, Chen E, Lokhnygina Y, Pei J, Leonardi S, Rorick TL, Killan AM, Jennings LHK, Amborsio G, Bode C, Cequier A, Cornel JH, Diaz R, Erkan A, Huber K, Hudson MP, Jiang L, Jukema W, Lewis BS, Lincoff M, Montalescot G, Nikolau JC, Ogawa H, Pfisterer M, Prieto JC, Ruzyllo W, Sinnaeve PR, Storey RF, Valgimigli M, Whellan DJ, Widimsky P, Strony J, Harrington RA, Mahaffey KW, the TRACER Investigators Airaksinen J

: 2012

: New England Journal of Medicine

: 366

: 1

: 20

: 33

: 14

: 0028-4793

DOI: https://doi.org/10.1056/NEJMoa1109719